EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Obesity‐related inflammatory protein signature in cardiovascular clinical outcomes: results from the Gutenberg Health Study

Marina Panova-Noeva iD, Thomas Koeck, Corinna Schoelch, Andreas Schulz, Jürgen H Prochaska, Matthias Michal, Konstantin Strauch, Alexander K Schuster, Karl J Lackner, Thomas Münzel, Anita M Hennige, Philipp S Wild

Obesity · 2024

DOI: 10.1002/oby.24014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity, 2024. Verfasst von Marina Panova-Noeva und 11 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. Hauptthemen laut MEDLINE: Obesity, Cardiovascular Diseases, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftung Rheinland-Pfalz für Innovation, "Wissen schafft Zukunft" and Center for Translational Vascular Biology (CTVB) of the Johannes Gutenberg University Mainz, Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to investigate whether an obesity‐related inflammatory protein signature (OIPS) is associated with adverse cardiovascular events.

Methods

The Olink Target 96 Inflammation panel was performed in 6662 participants from the population‐based Gutenberg Health Study (GHS). The OIPS was selected by a logistic regression model, and its association with cardiovascular outcomes was evaluated by Cox regression analysis. The GHS‐derived OIPS was externally validated in the MyoVasc study.

Results

The identified OIPS entailed 21 proteins involved in chemokine activity, tumor necrosis factor (TNF) receptor binding, and growth factor receptor binding. The signature revealed a novel positive association of axis inhibition protein 1 with obesity. The OIPS was associated with increased risk of all‐cause and cardiac deaths, major adverse cardiovascular events, and incident coronary artery disease, independent of clinical covariates and established risk instruments. A BMI‐stratified analysis confirmed the association of OIPS with increased death in those with obesity and overweight and with increased risk for coronary artery disease in those with obesity. The association of OIPS with increased risk of all‐cause and cardiac deaths was validated in the MyoVasc cohort.

Conclusions

The OIPS showed a significant association with adverse clinical outcomes, particularly in those with overweight and obesity, and represents a promising tool for identifying patients at higher risk for worse cardiovascular outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityCardiovascular DiseasesInflammationHumansFemaleMaleMiddle AgedAgedBody Mass IndexBiomarkersRisk FactorsAdultOverweight

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
  • Center for Thrombosis and Haemostasis, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
  • German Centre for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.
  • Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Department of Psychosomatic Medicine and Psychotherapy, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.

ORCID-Profile: Marina Panova-Noeva

Förderung

  • Stiftung Rheinland-Pfalz für Innovation
  • "Wissen schafft Zukunft" and Center for Translational Vascular Biology (CTVB) of the Johannes Gutenberg University Mainz
  • Boehringer Ingelheim
  • Philips Medical Systems
  • German Centre for Cardiovascular Research (DZHK)
  • Deutsches Zentrum für Herz-Kreislaufforschung

Zitieren

APA

Panova-Noeva, M., Koeck, T., Schoelch, C., Schulz, A., Prochaska, J. H., Michal, M., Strauch, K., Schuster, A. K., Lackner, K. J., Münzel, T., Hennige, A. M., & Wild, P. S. (2024). Obesity‐related inflammatory protein signature in cardiovascular clinical outcomes: results from the Gutenberg Health Study. Obesity. https://doi.org/10.1002/oby.24014

Vancouver

Panova-Noeva M, Koeck T, Schoelch C, Schulz A, Prochaska JH, Michal M, et al. Obesity‐related inflammatory protein signature in cardiovascular clinical outcomes: results from the Gutenberg Health Study. Obesity. 2024. doi:10.1002/oby.24014

BibTeX
@article{PanovaNoeva2024,
  author = {Panova-Noeva, Marina and Koeck, Thomas and Schoelch, Corinna and Schulz, Andreas and Prochaska, Jürgen H and Michal, Matthias and Strauch, Konstantin and Schuster, Alexander K and Lackner, Karl J and Münzel, Thomas and Hennige, Anita M and Wild, Philipp S},
  title = {Obesity‐related inflammatory protein signature in cardiovascular clinical outcomes: results from the Gutenberg Health Study},
  journal = {Obesity},
  year = {2024},
  doi = {10.1002/oby.24014}
}
Kostenlos starten →